| Authors: |
Dickmann CGF; Bio21 Institute, The University of Melbourne, Parkville, VIC 3010, Australia. whitejm@unimelb.edu.au.; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, and School of Cancer Medicine, La Trobe University, Heidelberg, Australia. uwea@unimelb.edu.au.; Department of Molecular Imaging and Therapy, Austin Hospital, Heidelberg, Australia., McDonald AF; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, and School of Cancer Medicine, La Trobe University, Heidelberg, Australia. uwea@unimelb.edu.au.; Department of Molecular Imaging and Therapy, Austin Hospital, Heidelberg, Australia., Huynh N; Department of Molecular Imaging and Therapy, Austin Hospital, Heidelberg, Australia., Rigopoulos A; Department of Molecular Imaging and Therapy, Austin Hospital, Heidelberg, Australia., Liu Z; Department of Molecular Imaging and Therapy, Austin Hospital, Heidelberg, Australia., Guo N; Department of Molecular Imaging and Therapy, Austin Hospital, Heidelberg, Australia., Osellame LD; Department of Molecular Imaging and Therapy, Austin Hospital, Heidelberg, Australia., Gorman MA; Bio21 Institute, The University of Melbourne, Parkville, VIC 3010, Australia. whitejm@unimelb.edu.au., Parker MW; Bio21 Institute, The University of Melbourne, Parkville, VIC 3010, Australia. whitejm@unimelb.edu.au.; ACRF Facility for Innovative Cancer Drug Discovery, Bio21 Institute, The University of Melbourne, Parkville, VIC 3010, Australia.; ACRF Rational Drug Discovery Centre, St. Vincent's Institute of Medical Research, VIC 3065, Australia., Gan HK; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, and School of Cancer Medicine, La Trobe University, Heidelberg, Australia. uwea@unimelb.edu.au., Scott AM; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, and School of Cancer Medicine, La Trobe University, Heidelberg, Australia. uwea@unimelb.edu.au.; Department of Molecular Imaging and Therapy, Austin Hospital, Heidelberg, Australia.; Faculty of Medicine, University of Melbourne, Parkville, Australia., Ackermann U; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, and School of Cancer Medicine, La Trobe University, Heidelberg, Australia. uwea@unimelb.edu.au.; Department of Molecular Imaging and Therapy, Austin Hospital, Heidelberg, Australia., Burvenich IJG; Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, and School of Cancer Medicine, La Trobe University, Heidelberg, Australia. uwea@unimelb.edu.au., White JM; Bio21 Institute, The University of Melbourne, Parkville, VIC 3010, Australia. whitejm@unimelb.edu.au. |
